Researchers continue to excited about the medication , a innovative dual treatment showing promising results in early trials for size management. It works by modulating several systems: GLP-1 and GIP, that , when stimulated, help control hunger and enhance energy expenditure . Early findings indicate noteworthy size reduction and likely advantages